BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2500028)

  • 1. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
    Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
    Bank N; Coco M; Aynedjian HS
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
    Craven PA; DeRubertis FR
    Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A; Ku L; Cohen MP
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
    Mauer SM; Steffes MW; Azar S; Brown DM
    Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
    Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
    Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium restriction corrects hyperfiltration of diabetes.
    Bank N; Lahorra G; Aynedjian HS; Wilkes BM
    Am J Physiol; 1988 May; 254(5 Pt 2):F668-76. PubMed ID: 3284388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
    Goldfarb S; Simmons DA; Kern EF
    Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
    Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
    Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
    Cohen MP
    Metabolism; 1986 Apr; 35(4 Suppl 1):55-9. PubMed ID: 3007926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition.
    Cohen MP; Klepser H
    Diabetes; 1988 May; 37(5):558-62. PubMed ID: 2834250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
    J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats.
    Goldfarb S; Ziyadeh FN; Kern EF; Simmons DA
    Diabetes; 1991 Apr; 40(4):465-71. PubMed ID: 2010046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat.
    Cameron NE; Leonard MB; Ross IS; Whiting PH
    Diabetologia; 1986 Mar; 29(3):168-74. PubMed ID: 3084324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.
    Körner A; Celsi G; Eklöf AC; Linné T; Persson B; Aperia A
    Diabetologia; 1992 May; 35(5):414-8. PubMed ID: 1521721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
    Pugliese G; Tilton RG; Speedy A; Chang K; Province MA; Kilo C; Williamson JR
    Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM; Sochor M; Hothersall JS; McLean P
    Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoregulatory hormones and the hyperfiltration of diabetes.
    Bank N; Lahorra MA; Aynedjian HS; Schlondorff D
    Am J Physiol; 1988 Feb; 254(2 Pt 2):F202-9. PubMed ID: 2449821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.